PD-L1-话题@MedSci

#PD-L1#

309篇内容 | 5711人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1254955, encodeId=38201254955e3, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=Lancet：震惊！PD-1/PD-L1免疫抑制剂或可出现致死性并发症！, objectType=article, longId=132932, objectId=7c6813293284, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c6813293284, replyNumber=0, likeNumber=43, createdTime=2018-03-21, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c6813293284, moduleTitle=Lancet：震惊！PD-1/PD-L1免疫抑制剂或可出现致死性并发症！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c6813293284)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254954, encodeId=f446125495466, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=BMJ：抗PD-L1药物免疫相关的不良事件！, objectType=article, longId=132477, objectId=327f1324e704, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=327f1324e704, replyNumber=0, likeNumber=58, createdTime=2018-03-16, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=327f1324e704, moduleTitle=BMJ：抗PD-L1药物免疫相关的不良事件！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=327f1324e704)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254953, encodeId=304c12549534d, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=JCO：DNA损伤反应和修复基因改变作为晚期尿路上皮癌PD-1/PD-L1阻断获益的标志物, objectType=article, longId=131112, objectId=8a26131112d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a26131112d7, replyNumber=0, likeNumber=60, createdTime=2018-03-03, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a26131112d7, moduleTitle=JCO：DNA损伤反应和修复基因改变作为晚期尿路上皮癌PD-1/PD-L1阻断获益的标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a26131112d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254952, encodeId=1e451254952a7, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=CLIN CANCER RES：头颈部肿瘤患者血浆PD-L1+外泌体的临床意义, objectType=article, longId=130922, objectId=91761309222a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91761309222a, replyNumber=0, likeNumber=74, createdTime=2018-03-02, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91761309222a, moduleTitle=CLIN CANCER RES：头颈部肿瘤患者血浆PD-L1+外泌体的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91761309222a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254951, encodeId=8f6212549516f, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=J Thorac Oncol:肺癌胸腔积液细胞PD-L1表达是肺癌患者免疫治疗的预后指标吗？, objectType=article, longId=130869, objectId=aaa31308691f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aaa31308691f, replyNumber=0, likeNumber=71, createdTime=2018-03-01, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aaa31308691f, moduleTitle=J Thorac Oncol:肺癌胸腔积液细胞PD-L1表达是肺癌患者免疫治疗的预后指标吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aaa31308691f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254950, encodeId=22b7125495027, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=CLIN CANCER RES：血管靶向光动力疗法可以增强PD-1/PD-L1通路阻滞抗肿瘤免疫反应, objectType=article, longId=130628, objectId=2e681306281d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e681306281d, replyNumber=0, likeNumber=83, createdTime=2018-02-27, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e681306281d, moduleTitle=CLIN CANCER RES：血管靶向光动力疗法可以增强PD-1/PD-L1通路阻滞抗肿瘤免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e681306281d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254949, encodeId=5be312549495c, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=JCO：非小细胞肺癌患者抗PD-1/PD-L1阻断治疗反应的分子决定因素, objectType=article, longId=126847, objectId=ac8812684e25, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac8812684e25, replyNumber=0, likeNumber=53, createdTime=2018-01-20, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac8812684e25, moduleTitle=JCO：非小细胞肺癌患者抗PD-1/PD-L1阻断治疗反应的分子决定因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac8812684e25)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254948, encodeId=6c4d125494840, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=Nature：CD4/6抑制剂通过增加PD-L1表达提高免疫检查点抑制剂的治疗效果, objectType=article, longId=125917, objectId=6df412591ef3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6df412591ef3, replyNumber=0, likeNumber=50, createdTime=2018-01-10, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6df412591ef3, moduleTitle=Nature：CD4/6抑制剂通过增加PD-L1表达提高免疫检查点抑制剂的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6df412591ef3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254947, encodeId=05eb125494e83, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=J Clin Oncol：PD-L1免疫组化检测：NSCLC中的分析及临床应用, objectType=article, longId=124802, objectId=d02e124802f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d02e124802f2, replyNumber=0, likeNumber=60, createdTime=2017-12-28, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d02e124802f2, moduleTitle=J Clin Oncol：PD-L1免疫组化检测：NSCLC中的分析及临床应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d02e124802f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254946, encodeId=4cb61254946e0, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=Oncotarget：PD-1 / PD-L1免疫检查点的小分子抑制剂能够减轻PD-L1诱导的T细胞耗竭, objectType=article, longId=124231, objectId=8f861242312e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f861242312e, replyNumber=0, likeNumber=85, createdTime=2017-12-23, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f861242312e, moduleTitle=Oncotarget：PD-1 / PD-L1免疫检查点的小分子抑制剂能够减轻PD-L1诱导的T细胞耗竭, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f861242312e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254945, encodeId=7ff612549453d, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=Lancet：Atezolizumab不能延长PD-L1过表达的铂难治性转移性尿路上皮癌患者生存期, objectType=article, longId=123956, objectId=a774123956b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a774123956b5, replyNumber=0, likeNumber=56, createdTime=2017-12-21, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a774123956b5, moduleTitle=Lancet：Atezolizumab不能延长PD-L1过表达的铂难治性转移性尿路上皮癌患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a774123956b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254944, encodeId=111112549446f, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=Clin Cancer Res：头颈部肿瘤患者血浆中PD-L1 +外泌体的临床意义, objectType=article, longId=123725, objectId=e13d123e25fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e13d123e25fc, replyNumber=0, likeNumber=80, createdTime=2017-12-18, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e13d123e25fc, moduleTitle=Clin Cancer Res：头颈部肿瘤患者血浆中PD-L1 +外泌体的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e13d123e25fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254943, encodeId=6977125494345, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=JCO：派姆单抗治疗晚期PD-L1阳性宫颈癌患者效果佳, objectType=article, longId=122519, objectId=7e5f122519c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e5f122519c5, replyNumber=0, likeNumber=0, createdTime=2017-12-08, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e5f122519c5, moduleTitle=JCO：派姆单抗治疗晚期PD-L1阳性宫颈癌患者效果佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e5f122519c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254942, encodeId=fa0812549428e, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=Lancet oncol：Avelumab，抗PD-L1单克隆抗体，为对铂类不敏感的转移性尿路上皮癌患者带来新的希望。, objectType=article, longId=122363, objectId=cb2d122363b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb2d122363b2, replyNumber=0, likeNumber=75, createdTime=2017-12-07, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb2d122363b2, moduleTitle=Lancet oncol：Avelumab，抗PD-L1单克隆抗体，为对铂类不敏感的转移性尿路上皮癌患者带来新的希望。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb2d122363b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254941, encodeId=cfb0125494184, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=CLIN CANCER RES：前列腺癌Neo-AAPL治疗与PD-L1表达, objectType=article, longId=120620, objectId=7bfc1206208e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bfc1206208e, replyNumber=0, likeNumber=76, createdTime=2017-11-20, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bfc1206208e, moduleTitle=CLIN CANCER RES：前列腺癌Neo-AAPL治疗与PD-L1表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bfc1206208e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254940, encodeId=6567125494014, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=Sci Trans Med：科学家给小鼠注射产生PD-L1的干细胞已成功逆转糖尿病！, objectType=article, longId=120352, objectId=c0b012035269, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0b012035269, replyNumber=0, likeNumber=0, createdTime=2017-11-18, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0b012035269, moduleTitle=Sci Trans Med：科学家给小鼠注射产生PD-L1的干细胞已成功逆转糖尿病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0b012035269)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254939, encodeId=fc841254939c3, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=JCO：Pembrolizumab治疗晚期PD-L1阳性宫颈癌的安全性和有效性, objectType=article, longId=118912, objectId=d9371189127f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9371189127f, replyNumber=0, likeNumber=140, createdTime=2017-11-07, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9371189127f, moduleTitle=JCO：Pembrolizumab治疗晚期PD-L1阳性宫颈癌的安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9371189127f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254938, encodeId=c15a12549387a, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=历史性一刻，BMS单抗Opdivo强势来袭，中国**款提交上市申请的PD-1/PD-L1类药物, objectType=article, longId=118721, objectId=3b83118e218f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b83118e218f, replyNumber=0, likeNumber=78, createdTime=2017-11-05, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b83118e218f, moduleTitle=历史性一刻，BMS单抗Opdivo强势来袭，中国**款提交上市申请的PD-1/PD-L1类药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b83118e218f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254937, encodeId=fd77125493efb, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=CLIN CANCER RES：PD-L1表达与黑色素瘤免疫逃逸, objectType=article, longId=118029, objectId=117b118029b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=117b118029b5, replyNumber=0, likeNumber=81, createdTime=2017-10-31, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=117b118029b5, moduleTitle=CLIN CANCER RES：PD-L1表达与黑色素瘤免疫逃逸, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=117b118029b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254936, encodeId=4f781254936e9, content=<a href='/topic/show?id=be71139214f' target=_blank style='color:#2F92EE;'>#PD-L1#</a>, objectTitle=专访迈博斯CEO钱雪明：我们在做，全球pH依赖性结合PD-L1抗体, objectType=article, longId=115154, objectId=e6ea11515442, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6ea11515442, replyNumber=0, likeNumber=88, createdTime=2017-10-04, rootId=0, userName=smartjoy, userId=e76f39, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6ea11515442, moduleTitle=专访迈博斯CEO钱雪明：我们在做，全球pH依赖性结合PD-L1抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6ea11515442)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PD-L1

2020-05-29

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

Lancet：震惊！PD-1/PD-L1免疫抑制剂或可出现致死性并发症！

2018-03-21

仁医06 (审核中...)

前往app查看评论内容

#PD-L1#

BMJ：抗PD-L1药物免疫相关的不良事件！

2018-03-16

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

JCO：DNA损伤反应和修复基因改变作为晚期尿路上皮癌PD-1/PD-L1阻断获益的标志物

2018-03-03

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

CLIN CANCER RES：头颈部肿瘤患者血浆PD-L1+外泌体的临床意义

2018-03-02

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

J Thorac Oncol:肺癌胸腔积液细胞PD-L1表达是肺癌患者免疫治疗的预后指标吗？

2018-03-01

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

CLIN CANCER RES：血管靶向光动力疗法可以增强PD-1/PD-L1通路阻滞抗肿瘤免疫反应

2018-02-27

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

JCO：非小细胞肺癌患者抗PD-1/PD-L1阻断治疗反应的分子决定因素

2018-01-20

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

Nature：CD4/6抑制剂通过增加PD-L1表达提高免疫检查点抑制剂的治疗效果

2018-01-10

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

J Clin Oncol：PD-L1免疫组化检测：NSCLC中的分析及临床应用

2017-12-28

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

Oncotarget：PD-1 / PD-L1免疫检查点的小分子抑制剂能够减轻PD-L1诱导的T细胞耗竭

2017-12-23

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

Lancet：Atezolizumab不能延长PD-L1过表达的铂难治性转移性尿路上皮癌患者生存期

2017-12-21

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

Clin Cancer Res：头颈部肿瘤患者血浆中PD-L1 +外泌体的临床意义

2017-12-18

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

JCO：派姆单抗治疗晚期PD-L1阳性宫颈癌患者效果佳

2017-12-08

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

Lancet oncol：Avelumab，抗PD-L1单克隆抗体，为对铂类不敏感的转移性尿路上皮癌患者带来新的希望。

2017-12-07

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

CLIN CANCER RES：前列腺癌Neo-AAPL治疗与PD-L1表达

2017-11-20

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

Sci Trans Med：科学家给小鼠注射产生PD-L1的干细胞已成功逆转糖尿病！

2017-11-18

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

JCO：Pembrolizumab治疗晚期PD-L1阳性宫颈癌的安全性和有效性

2017-11-07

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

历史性一刻，BMS单抗Opdivo强势来袭，中国**款提交上市申请的PD-1/PD-L1类药物

2017-11-05

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

CLIN CANCER RES：PD-L1表达与黑色素瘤免疫逃逸

2017-10-31

smartjoy (审核中...)

前往app查看评论内容

#PD-L1#

专访迈博斯CEO钱雪明：我们在做，全球pH依赖性结合PD-L1抗体

2017-10-04

科室
- - 订阅+
  - 更多科室
工具
服务